Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting a severe middle ear infection, based on results of a study done in mice by investigators from St. Jude Children’s Research Hospital and The Rockefeller University, in New York.
GlaxoSmithKline (GSK) announced that its new, novel topical antibiotic ALTARGO? (retapamulin ointment, 1%) received a positive opinion from the European Committee for Human Medicinal Products (CHMP) for the treatment of impetigo and infected small lacerations, abrasions or sutured wounds.
A study published today in the Journal of Antimicrobial Chemotherapy provides the best available evidence that cases of Clostridium difficile infection (CDI) — one of the most common and increasing types of hospital-acquired infection — can be reduced in hospital wards if doctors prescribe narrow-spectrum antibiotics rather than broad-spectrum agents.
Using lysins, a protein from viruses that infect bacteria, scientists have developed a novel way to prevent kids from developing middle ear infections.
A small piece of DNA that helps bacteria commonly found in US meat and poultry resist several antibiotics has also been found in the plague bacillus Yersinia pestis, gene sequence researchers report.
Antibiotics are prescribed for approximately 82 percent of acute sinus infections and nearly 70 percent of chronic sinus infections, despite the fact that viruses are by far the most frequent cause of this condition, according to a report in the March issue of Archives of Otolaryngology — Head & Neck Surgery, one of the JAMA/Archives journals.
Research by a team at the University of Cincinnati (UC) has helped in the discovery of a new way to fight antibiotic-resistant bacteria, responsible for preventing treatment of lung infections in patients with cystic fibrosis and life-threatening cases of pneumonia.
Scientists hoping to find new treatments for one of the world?s most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.
The first detailed images of an elusive drug target on the outer wall of bacteria may provide scientists with enough new information to aid design of novel antibiotics. The drugs are much needed to treat deadly infections initiated by Staphylococcus aureus and other bacterial pathogens.
Two researchers from the University Hospital and the Center for Applied Medical Research (CIMA) from the University of Navarra have published an article in Nature Cancer Reviews.